Low molecular weight heparins and bleeding

Semin Thromb Hemost. 1989 Oct;15(4):401-4. doi: 10.1055/s-2007-1002738.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Drug Evaluation, Preclinical
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage / chemically induced*
  • Heparin / toxicity
  • Heparin, Low-Molecular-Weight / adverse effects*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Heparin, Low-Molecular-Weight / toxicity
  • Heparinoids / adverse effects*
  • Heparinoids / therapeutic use
  • Humans
  • Rabbits
  • Rats
  • Thrombophlebitis / prevention & control

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Heparinoids
  • Heparin